The Department of Science and Technology (DOST) and Adamson University (AdU) teamed up to produce safe, effective, and cost-efficient tablets for stroke patients.
Funded under the Collaborative Research and Development to Leverage Philippine Economy (CRADLE) Program of the Science for Chance (S4C) Program of DOST-Philippine Council for Health Research and Development, the two-year project aims to produce tablet formulations of a fixed-dose combination of cilostazol and aspirin.
"Once completed, the project could potentially provide patients suffering from stroke, thromboembolic disorders, and ischemic heart disease, safe, compatible, stable, and effective generic medications that are cheaper than the counterpart innovator products of each drug available as separate tablet formulations," DOST Secretary Fortunato de la Peña said in a taped report.
"The optimized fixed-dose formulation is also expected to minimize adverse drug reactions, reduce anticipated medication errors associated with dispensing and enhance dosage compliance," he added.
The research is led by Dr. Gerard de Guzman of AdU in partnership with Compact Pharmaceuticals Inc. and commenced in February 2021 with funding support from DOST amounting to P4.97 million.